Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Jazz Pharmaceuticals (JAZZ) has issued an update.
Catherine Sohn, Pharm.D. has informed Jazz Pharmaceuticals that she will retire and not seek re-election to the company’s board at the upcoming 2024 annual meeting. Her departure is amicable, with no disputes or disagreements with the company’s operations, policies, or practices mentioned as a reason for her retirement.
Find detailed analytics on JAZZ stock on TipRanks’ Stock Analysis page.